Am J Obstet Gynecol

1. KARSTENSEN S, Jochumsen K, Hogdall C, Hogdall E, et al
   Ovarian sex cord-stromal cell tumors and the risk of sex hormone-sensitive cancers.
   Am J Obstet Gynecol. 2025 Jan 21:S0002-9378(25)00029.
   

   >> Share

   
   

   
   Anticancer Drugs

2. WANG Y, Xu Z, He C, Qu H, et al
   E26 transformation-specific transcription factor 3 tips the balance: repressing tropomyosin 2 to fuel Yes-associated protein 1-driven cisplatin resistance in ovarian cancer.
   Anticancer Drugs. 2025 Aug 1. doi: 10.1097/CAD.0000000000001761.
   

   >> Share

   
   

   
   Clin Cancer Res

3. KNISELY A, Dai Y, Barlow GL, Lee S, et al
   Surgical and blood-based minimal residual disease in patients with ovarian cancer after frontline therapy: Clinical outcomes and translational opportunities.
   Clin Cancer Res. 2025 Aug 1. doi: 10.1158/1078-0432.CCR-25-0512.
   

   >> Share

   
   

   
   Curr Opin Obstet Gynecol

4. MCLOUGHLIN K, Merritt MA
   Opportunistic salpingectomy for prevention of ovarian cancer among the general population.
   Curr Opin Obstet Gynecol. 2025 Jul 22. doi: 10.1097/GCO.0000000000001051.
   

   >> Share

   
   

   
   Eur J Obstet Gynecol Reprod Biol

5. BILLMIRE DF, Turk F, Harris AK, Muraru R, et al
   Surgical staging for ovarian sex cord-stromal tumors: What procedural steps are needed?
   Eur J Obstet Gynecol Reprod Biol. 2025;312:114522.
   

   >> Share

   
   
6. RAY MD, Kapoor R
   Paraneoplastic syndromes in ovarian carcinoma: A study on clinical spectrum, treatment and survival perspectives.
   Eur J Obstet Gynecol Reprod Biol. 2025;312:114114.
   

   >> Share

   
   
7. RAY MD, Kapoor R, Banthia P
   The nodal cancer index (NCI): An objective approach for systematic lymph node dissection in ovarian carcinomatosis.
   Eur J Obstet Gynecol Reprod Biol. 2025;312:114113.
   

   >> Share

   
   
8. LI J, Lu L, Duan J, Gu P, et al
   Fertility-sparing strategies in borderline and malignant ovarian tumors: a comparative analysis of international guideline recommendations.
   Eur J Obstet Gynecol Reprod Biol. 2025;312:114111.
   

   >> Share

   
   
9. YOONG W, Penny Z, Ho J, Ariyo O, et al
   Outcomes and cost-effectiveness of vNOTES vs conventional laparoscopic ovarian cystectomy for ovarian teratoma (dermoid cysts): A comparison of two minimal access routes of surgery.
   Eur J Obstet Gynecol Reprod Biol. 2025;312:114087.
   

   >> Share

   
   

   
   Gynecol Oncol

10. WANG JY, Simons EJ, Dingel A, Pike MM, et al
    Impact of chemotherapy provider specialty on outcomes in ovarian cancer.
    Gynecol Oncol. 2025;200:122-129.
    

    >> Share

    
    

    
    Int J Gynaecol Obstet

11. VO HL, Tran DT, Le LH, Nguyen TTN, et al
    Comparative diagnostic performance of the early-stage ovarian malignancy score versus other risk prediction models in early-stage ovarian cancer: A Vietnamese prospective cohort study.
    Int J Gynaecol Obstet. 2025 Jul 31. doi: 10.1002/ijgo.70383.
    

    >> Share

    
    

    
    J Natl Cancer Inst

12. JONES RR, Madrigal JM, Medgyesi DN, Fisher JA, et al
    Serum concentrations of per- and polyfluoroalkyl substances and risk of ovarian cancer.
    J Natl Cancer Inst. 2025 Aug 1:djaf204. doi: 10.1093.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share